We propose that TMB instead may be a good surrogate biomarker for MSI, as a range of 30–80 mut/Mb is typically seen in MSI tumours, as opposed to MSS POLE/POLD1 tumours, which typically have greater than 150 mut/Mb. The gene discussed is POLD1; the disease is neoplasm.